Hs 944.THomo sapiens (Human)Cancer cell line

Also known as: HS944, Hs 944, HS 944, HS944T, Hs944T, HS 944T, HS-944-T, Hs-944-T, Hs-994

🤖 AI SummaryBased on 6 publications

Quick Overview

Human melanoma cell line with known mutations in NRAS and BRAF, used in cancer research.

Detailed Summary

Hs 944.T is a human melanoma cell line derived from a primary tumor. It is characterized by specific genetic mutations in NRAS and BRAF, which are frequently associated with melanoma progression. This cell line is utilized in research to study the molecular mechanisms of melanoma, including the interactions between RAS signaling pathways and tumor development. The presence of these mutations makes it a valuable model for investigating targeted therapies and understanding the genetic basis of cancer progression. Additionally, Hs 944.T has been used in studies examining the role of PTEN/MMAC1 inactivation in conjunction with BRAF mutations, highlighting its importance in melanoma research.

Research Applications

Cancer researchMelanoma studiesGenetic mutation analysisTargeted therapy development

Key Characteristics

NRAS mutationBRAF mutationPTEN/MMAC1 inactivation
Generated on 6/16/2025

Basic Information

Database IDCVCL_1040
SpeciesHomo sapiens (Human)

Donor Information

Age51
Age CategoryAdult
SexMale
Racecaucasian

Disease Information

DiseaseCutaneous melanoma
LineageSkin
SubtypeCutaneous Melanoma
OncoTree CodeSKCM

DepMap Information

Source TypeATCC
Source IDACH-000632_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Lys382Asnfs*40 (c.1146delA)Heterozygous-Unknown, Unknown
MutationSimpleTERTc.242_243CC>TT (-138/-139CC>TT)UnspecifiedIn promoterPubMed=23348503
MutationSimplePTENp.Lys163fs (c.486_487insA)Heterozygous-Unknown
MutationSimpleNRASp.Gln61Lys (c.181C>A)UnspecifiedAcquired during resistance selection processPubMed=26214590
MutationSimpleFBXW7p.Arg479Gln (c.1436G>A)Heterozygous-Unknown, Unknown
MutationSimpleCDKN2Ap.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T)Unspecified-PubMed=11787853
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.

Nat. Commun. 10:3574.1-3574.11(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.

Golub T.R., Root D.E., Hahn W.C.

Sci. Data 1:140035-140035(2014).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.

Tsao H., Goel V., Wu H., Yang G., Haluska F.G.

J. Invest. Dermatol. 122:337-341(2004).

Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.

Tsao H., Zhang X., Fowlkes K., Haluska F.G.

Cancer Res. 60:1800-1804(2000).

Relationship between karyotype of tissue culture lines and tumorigenicity in nude mice.

Gershwin M.E., Lentz D., Owens R.B.

Exp. Cell Biol. 52:361-370(1984).